BioCentury
ARTICLE | Distillery Techniques

Techniques: Mesenchymal stem cell (MSC) screen for oncogenic drivers of undifferentiated sarcomas

February 26, 2015 8:00 AM UTC

An MSC model could help identify therapeutics to treat undifferentiated sarcomas. In isolated MSC-enriched mouse bone marrow cells, p53 depletion plus expression of known sarcoma oncogenes induced sar...